Does DAPSONE Cause Product use in unapproved indication? 168 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 168 reports of Product use in unapproved indication have been filed in association with DAPSONE (Dapsone). This represents 5.1% of all adverse event reports for DAPSONE.
168
Reports of Product use in unapproved indication with DAPSONE
5.1%
of all DAPSONE reports
6
Deaths
23
Hospitalizations
How Dangerous Is Product use in unapproved indication From DAPSONE?
Of the 168 reports, 6 (3.6%) resulted in death, 23 (13.7%) required hospitalization, and 21 (12.5%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPSONE. However, 168 reports have been filed with the FAERS database.
What Other Side Effects Does DAPSONE Cause?
Drug ineffective (673)
Off label use (506)
Drug reaction with eosinophilia and systemic symptoms (345)
Methaemoglobinaemia (322)
Treatment failure (260)
Condition aggravated (166)
Pyrexia (156)
Drug ineffective for unapproved indication (134)
Anaemia (117)
Haemolytic anaemia (101)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which DAPSONE Alternatives Have Lower Product use in unapproved indication Risk?
DAPSONE vs DAPTOMYCIN
DAPSONE vs DARATUMUMAB
DAPSONE vs DARATUMUMAB\HYALURONIDASE-FIHJ
DAPSONE vs DARBEPOETIN ALFA
DAPSONE vs DARIDOREXANT